Videos, Slides, Films

Ecstacy for PTSD: The Multidisciplinary Association for Psychedelic Studies (MAPS) Project

Available as
Online
Summary

Ecstacy (MDMA) is in Phase 2 FDA trials for use as a therapeutic aid for people suffering from post-traumatic stress disorder. In this video, Multidisciplinary Association for Psychedelic Studies (...

Ecstacy (MDMA) is in Phase 2 FDA trials for use as a therapeutic aid for people suffering from post-traumatic stress disorder. In this video, Multidisciplinary Association for Psychedelic Studies (MAPS) Project founder Rick Doblin and psychiatrist Michael Mithoefer talk about the results so far and what the future looks like for MDMA as a therapeutic tool.

Details

Additional Information